SAFETY AND EFFECTIVENESS OF PEMETREXED IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN JAPAN BASED ON POST-MARKETING SURVEILLANCE

被引：0
|
作者：
Okubo, Sumiko [1 ]
Kobayashi, Noriko [1 ]
Taketsuna, Masanori [1 ]
Enatsu, Sotaro [1 ]
Nishiuma, Shinichi [1 ]
机构：
[1] Eli Lilly Japan, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 11期
关键词：
Post-Marketing Surveillance; NSCLC; Pemetrexed;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-011
引用
收藏
页码：S485 / S485
页数：1
相关论文
共 50 条
  • [1] Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance
    Sharareh Seifi
    Babak Salimi
    Zahra Esfahani Monfared
    Cyrus Sabahi
    Hamidreza Kafi
    Adnan Khosravi
    Journal of Pharmaceutical Policy and Practice, 16
  • [2] Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance
    Seifi, Sharareh
    Salimi, Babak
    Monfared, Zahra Esfahani
    Sabahi, Cyrus
    Kafi, Hamidreza
    Khosravi, Adnan
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [3] Real-world outcomes of pembrolizumab monotherapy in non-small cell lung cancer in Japan: A post-marketing surveillance
    Yamamoto, Nobuyuki
    Kamitani, Tetsu
    Kanda, Kingo
    Ito, Yuichiro
    Hamada, Masahiro
    Ozaki, Masahiko
    Takeuchi, Noriko
    Yamada, Tomoko
    Kawano, Masaki
    Maekawa, Shinichiroh
    Kato, Terufumi
    CANCER SCIENCE, 2022, 113 (09) : 3110 - 3119
  • [4] Real-world safety of nivolumab in patients with non-small cell lung cancer (NSCLC) in Japan: Interim summary of post-marketing all-case surveillance
    Ohe, Y.
    Gemma, A.
    Nakagawa, K.
    Yamamoto, N.
    Saito, T.
    Akamatsu, A.
    Kuwano, K.
    Nakanishi, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] Safety and Effectiveness of Brigatinib in Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) in Argentina: A Post-Marketing Surveillance Study
    Martin, Claudio
    Malcervelli, Gabriela Ileana
    Martinengo, Gaston Lucas
    Levit, Patricio
    Servienti, Patricio
    Malaver, Elisa
    Brion, Laura
    Patronella, Vanesa
    Zumarraga, Andrea
    Zarba, Jose
    DRUGS-REAL WORLD OUTCOMES, 2025,
  • [6] Post-marketing surveillance of the safety of levofloxacin in Japan
    Yamaguchi, Hiroki
    Kawai, Hitomi
    Matsumoto, Takuyuki
    Yokoyama, Hiroo
    Nakayasu, Toshio
    Komiya, Masahiro
    Shimada, Jingoro
    CHEMOTHERAPY, 2007, 53 (02) : 85 - 103
  • [7] Safety and effectiveness of avelumab in patients with Merkel cell carcinoma in general clinical practice in Japan: Post-marketing surveillance
    Uhara, Hisashi
    Kiyohara, Yoshio
    Isei, Taiki
    Nagase, Kotaro
    Kambe, Anzu
    Sato, Masashi
    Tanaka, Yutaro
    Yamazaki, Naoya
    JOURNAL OF DERMATOLOGY, 2024, 51 (04): : 475 - 483
  • [8] Safety and Effectiveness of Gemcitabine in 855 Patients with Pancreatic Cancer under Japanese Clinical Practice Based on Post-marketing Surveillance in Japan
    Ioka, Tatsuya
    Katayama, Kazuhiro
    Tanaka, Sachiko
    Takakura, Rena
    Ashida, Reiko
    Kobayashi, Noriko
    Taniai, Hisashi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (02) : 139 - 145
  • [9] Safety and Effectiveness of Gemcitabine in 260 Patients with Biliary Tract Cancer in a Japanese Clinical Practice Based on Post-marketing Surveillance in Japan
    Okubo, Sumiko
    Nishiuma, Shinichi
    Kobayashi, Noriko
    Taketsuna, Masanori
    Taniai, Hisashi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (11) : 1043 - 1053
  • [10] Safety and effectiveness of rasagiline in patients with Parkinson's disease in Japan: a post-marketing surveillance study
    Hattori, Nobutaka
    Kajita, Mika
    Fujimoto, Shinji
    Izutsu, Miwa
    Fernandez, Jovelle
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (01) : 79 - 88
12345